vs
Side-by-side financial comparison of Pfizer (PFE) and Sunoco LP (SUN). Click either name above to swap in a different company.
Pfizer is the larger business by last-quarter revenue ($14.5B vs $10.7B, roughly 1.4× Sunoco LP). Pfizer runs the higher net margin — 18.6% vs 6.0%, a 12.6% gap on every dollar of revenue. On growth, Sunoco LP posted the faster year-over-year revenue change (106.4% vs 5.0%). Over the past eight quarters, Sunoco LP's revenue compounded faster (31.6% CAGR vs 4.3%).
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer (1824–1906) and Charles F. Erhart (1821–1891), Pfizer is one of the oldest pharmaceutical companies in North America.
Sunoco LP is an American vehicle gasoline master limited partnership company organized under Delaware state law and headquartered in Dallas, Texas. Dating back to 1886, the company has transformed from a vertically integrated energy company to a distributor of fuels and operator of energy infrastructure. It was previously engaged in oil, natural gas exploration and production, refining, chemical manufacturing, and retail fuel sales, but divested these businesses.
PFE vs SUN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $14.5B | $10.7B |
| Net Profit | $2.7B | $644.0M |
| Gross Margin | — | 13.1% |
| Operating Margin | — | 8.1% |
| Net Margin | 18.6% | 6.0% |
| Revenue YoY | 5.0% | 106.4% |
| Net Profit YoY | — | 211.1% |
| EPS (diluted) | $0.47 | $2.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $14.5B | $10.7B | ||
| Q4 25 | $17.6B | $8.6B | ||
| Q3 25 | $16.7B | $6.0B | ||
| Q2 25 | $14.7B | $5.4B | ||
| Q1 25 | $13.7B | $5.2B | ||
| Q4 24 | $17.8B | $5.3B | ||
| Q3 24 | $17.7B | $5.8B | ||
| Q2 24 | $13.3B | $6.2B |
| Q1 26 | $2.7B | $644.0M | ||
| Q4 25 | $-1.6B | $101.0M | ||
| Q3 25 | $3.5B | $133.0M | ||
| Q2 25 | $2.9B | $86.0M | ||
| Q1 25 | $3.0B | $207.0M | ||
| Q4 24 | $410.0M | $141.0M | ||
| Q3 24 | $4.5B | $2.0M | ||
| Q2 24 | $41.0M | $493.0M |
| Q1 26 | — | 13.1% | ||
| Q4 25 | 70.0% | 10.7% | ||
| Q3 25 | 74.9% | 10.7% | ||
| Q2 25 | 74.2% | 10.6% | ||
| Q1 25 | 79.3% | 12.6% | ||
| Q4 24 | 66.7% | 11.9% | ||
| Q3 24 | 70.3% | 7.4% | ||
| Q2 24 | 75.2% | 9.2% |
| Q1 26 | — | 8.1% | ||
| Q4 25 | -9.4% | 2.1% | ||
| Q3 25 | 20.0% | 4.2% | ||
| Q2 25 | 20.8% | 3.8% | ||
| Q1 25 | 20.3% | 5.7% | ||
| Q4 24 | -0.1% | 4.5% | ||
| Q3 24 | 26.6% | 1.9% | ||
| Q2 24 | -0.8% | 2.4% |
| Q1 26 | 18.6% | 6.0% | ||
| Q4 25 | -9.4% | 1.2% | ||
| Q3 25 | 21.3% | 2.2% | ||
| Q2 25 | 19.9% | 1.6% | ||
| Q1 25 | 21.6% | 4.0% | ||
| Q4 24 | 2.3% | 2.7% | ||
| Q3 24 | 25.2% | 0.0% | ||
| Q2 24 | 0.3% | 8.0% |
| Q1 26 | $0.47 | $2.85 | ||
| Q4 25 | $-0.29 | — | ||
| Q3 25 | $0.62 | — | ||
| Q2 25 | $0.51 | — | ||
| Q1 25 | $0.52 | — | ||
| Q4 24 | $0.07 | — | ||
| Q3 24 | $0.78 | — | ||
| Q2 24 | $0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $718.0M |
| Total DebtLower is stronger | — | $12.0M |
| Stockholders' EquityBook value | — | $8.3B |
| Total Assets | — | $30.3B |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $718.0M | ||
| Q4 25 | $1.1B | $891.0M | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.0B | $94.0M | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — |
| Q1 26 | — | $12.0M | ||
| Q4 25 | — | $13.4B | ||
| Q3 25 | — | $9.5B | ||
| Q2 25 | — | $7.8B | ||
| Q1 25 | — | $7.7B | ||
| Q4 24 | — | $7.5B | ||
| Q3 24 | — | $7.3B | ||
| Q2 24 | — | $7.3B |
| Q1 26 | — | $8.3B | ||
| Q4 25 | $86.5B | — | ||
| Q3 25 | $92.8B | — | ||
| Q2 25 | $88.7B | — | ||
| Q1 25 | $90.3B | — | ||
| Q4 24 | $88.2B | — | ||
| Q3 24 | $92.3B | — | ||
| Q2 24 | $87.7B | — |
| Q1 26 | — | $30.3B | ||
| Q4 25 | $208.2B | $28.4B | ||
| Q3 25 | $208.7B | $17.8B | ||
| Q2 25 | $206.1B | $14.4B | ||
| Q1 25 | $208.0B | $14.3B | ||
| Q4 24 | $213.4B | $14.4B | ||
| Q3 24 | $219.5B | $14.1B | ||
| Q2 24 | $216.2B | $14.5B |
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PFE
| Product revenues | $11.7B | 81% |
| Alliance revenues | $2.3B | 16% |
| Royalty revenues | $396.0M | 3% |
SUN
Segment breakdown not available.
